- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
SynAct Pharma AB (SYNACT)
SynAct Pharma AB stock price live, this page displays ST SYNACT stock exchange data. View the SYNACT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the SynAct Pharma AB real time stock price chart below.
What Is the SynAct Pharma AB Stock Price Today?
The SynAct Pharma AB stock price today is 11.04.
What Is the Stock Symbol for SynAct Pharma AB?
The stock symbol for SynAct Pharma AB is "SYNACT."
What Stock Exchange Does SynAct Pharma AB Trade On?
SynAct Pharma AB is listed and trades on the Stockholm stock exchange.
Is SynAct Pharma AB a Good Stock to Buy?
Determining whether SynAct Pharma AB, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SYNACT quote. (ISIN: SE0008241491) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
What Is the SynAct Pharma AB Stock Price Today?
The SynAct Pharma AB stock price today is 11.04.
What Is the Stock Symbol for SynAct Pharma AB?
The stock symbol for SynAct Pharma AB is "SYNACT."
What Stock Exchange Does SynAct Pharma AB Trade On?
SynAct Pharma AB is listed and trades on the Stockholm stock exchange.
Is SynAct Pharma AB a Good Stock to Buy?
Determining whether SynAct Pharma AB, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SYNACT quote. (ISIN: SE0008241491) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
Stockholm
Currency in SEK
11.04
-1.06(-8.76%)
Closed·
Fair Value
An estimate of a SynAct Pharma AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.04
12.48
52 wk Range
7.05
25.30
Unusual trading volume
1/2
Fair Value
An estimate of a SynAct Pharma AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.0412.48
52 wk Range
7.0525.30
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SYNACT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a SynAct Pharma AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
May 27, 2026
EPS / Forecast
-0.48 / --
Revenue / Forecast
-- / --
Compare SYNACT to Peers and Sector
Metrics to compare | SYNACT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSYNACTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.5x | −2.9x | −0.5x | |
PEG Ratio | 0.48 | −0.11 | 0.00 | |
Price/Book | 3.1x | 5.5x | 2.6x | |
Price / LTM Sales | - | 285.1x | 3.0x | |
Upside (Analyst Target) | 206.4% | 0.0% | 58.6% | |
Fair Value Upside | Unlock | 33.7% | 10.2% | Unlock |
SynAct Pharma AB, a clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden. The company develops AP1189, a drug candidate in Phase 2 clinical trial for the treatment of rheumatoid arthritis; host targeted treatment for viral infections such as respiratory infections, dengue virus, as well as polymyalgia rheumatica (PMR); and idiopathic membranous nephropathy. It is also developing TXP-11, an advanced peptide agonist that is in preclinical trials for the prevention of organ failure in surgery; and various drug programs to treat auto-immune and inflammatory diseases. SynAct Pharma AB was founded in 2012 and is headquartered in Lund, Sweden.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the SynAct Pharma AB (SYNACT) Stock Price Today?
The SynAct Pharma AB stock price today is 11.04 SEK.
What Stock Exchange Does SynAct Pharma AB Trade On?
SynAct Pharma AB is listed and trades on the Stockholm Stock Exchange.
What Is the Stock Symbol for SynAct Pharma AB?
The stock symbol for SynAct Pharma AB is "SYNACT."
What Is the SynAct Pharma AB Market Cap?
As of today, SynAct Pharma AB market cap is 643.89M SEK.
What Is SynAct Pharma AB's Earnings Per Share (TTM)?
The SynAct Pharma AB EPS (TTM) is -2.14.
When Is the Next SynAct Pharma AB Earnings Date?
SynAct Pharma AB will release its next earnings report on Aug 20, 2026.
From a Technical Analysis Perspective, Is SYNACT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has SynAct Pharma AB Stock Split?
SynAct Pharma AB has split 0 times.
How Many Employees Does SynAct Pharma AB Have?
SynAct Pharma AB has 8 employees.
What is the current trading status of SynAct Pharma AB (SYNACT)?
As of Jun 16, 2026, SynAct Pharma AB (SYNACT) is trading at a price of 11.04 SEK, with a previous close of 12.10 SEK. The stock has fluctuated within a day range of 11.04 SEK to 12.48 SEK, while its 52-week range spans from 7.05 SEK to 25.30 SEK.
What Is SynAct Pharma AB (SYNACT) Price Target According to Analysts?
The average 12-month price target for SynAct Pharma AB is 35.05 SEK, with a high estimate of 40.1 SEK and a low estimate of 30 SEK. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +217.48% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.